This site is intended for healthcare professionals only
LoginRegister
USFDA accepts Biologics License Application for proposed biosimilar denosumab: SandozUSFDA accepts Biologics License Application for proposed biosimilar denosumab: Sandoz
Dr Reddys Prepares Generic Semaglutide Entry Under Brand Obeda, Targets 60% Price Cut: ReportDr Reddy's gets CDSCO panel nod to manufacture, market lipid-regulating agent Icosapent ethyl...
Akums Drugs and Pharma bags DCGI nod to unveil type 2 diabetes drug Lobeglitazone in IndiaAkums Drugs and Pharma bags DCGI nod to unveil type 2 diabetes drug Lobeglitazone in India
State drugs regulators should be merged with CDSCO to ensure one quality one standard: Bharat Biotech MDState drugs regulators should be merged with CDSCO to ensure "one quality one standard": Bharat...
CDSCO suspends manufacturing of eye drops linked to 55 adverse events in USCDSCO suspends manufacturing of eye drops linked to 55 adverse events in US
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPalbociclib Sale: Delhi HC orders firm to pay Rs 2 crore damages to Pfizer
CM Yogi says UP to emerge as pharmaceutical hub in IndiaCM Yogi says UP to emerge as pharmaceutical hub in India
Lupin Secures USFDA Nod for Epilepsy Drug Brivaracetam in USLupin arm recalls 5,720 tubes of Clobetasol propionate Cream in US over manufacturing issue
Bharat Biotech Gets SEC Nod to Begin Phase III Trial of Inactivated Chikungunya VaccineBharat Biotech dispatches three lakh doses of intranasal COVID vaccine to hospitals
CDSCO Panel Tells Synokem to conduct phase 3 CT of antidiabetic FDC drugCDSCO Panel Tells Synokem to conduct phase 3 CT of antidiabetic FDC drug
CDSCO Panel grants Cadila Healthcares protocol amendment for Saroglitazar TabletsCDSCO Panel grants Cadila Healthcare's protocol amendment for Saroglitazar Tablets
Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case StudyGlenmark Gets CDSCO panel nod for Phase IV CT of Fosnetupitant, Palanosetron FDC drug
X